Clarity Medical Group Files Director List with HKEX

Reuters01-22
<a href="https://laohu8.com/S/01406">Clarity Medical</a> Group Files Director List with HKEX

Clarity Medical Group Holding Ltd. has filed an updated list of directors and their respective roles with the Hong Kong Stock Exchange. The board is led by Executive Director and Chief Executive Officer Mr. Jiang Bo. The Non-executive Directors are Mr. Chen Jiarong, Professor Wang Qinmei, and Mr. Sun Peng. Independent Non-executive Directors include Mr. Wang Can, Ms. Ci Ying, Dr. Chen Poujian, and Mr. Xu Anliang. The company’s Audit Committee is chaired by Mr. Wang Can, with members Ms. Ci Ying, Dr. Chen Poujian, and Mr. Xu Anliang. The Remuneration Committee is also chaired by Mr. Wang Can, joined by Ms. Ci Ying and Mr. Chen Jiarong. The Nomination Committee is chaired by Ms. Ci Ying, with Mr. Chen Jiarong and Mr. Wang Can serving as members.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clarity Medical Group Holding Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260122-11998982), on January 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment